DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells.
Saiki Y, Yoshino Y, Fujimura H, Manabe T, Kudo Y, Shimada M, Mano N, Nakano T, Lee Y, Shimizu S, Oba S, Fujiwara S, Shimizu H, Chen N, Nezhad ZK, Jin G, Fukushige S, Sunamura M, Ishida M, Motoi F, Egawa S, Unno M, Horii A.
Saiki Y, et al. Among authors: yoshino y.
Biochem Biophys Res Commun. 2012 Apr 27;421(1):98-104. doi: 10.1016/j.bbrc.2012.03.122. Epub 2012 Apr 3.
Biochem Biophys Res Commun. 2012.
PMID: 22490663